Profil
Anthony Robert Rees is the founder of Oxford Molecular Group Plc, Sulis Innovation Ltd. He currently serves as the Chairman of SpinChem AB. He previously served as the Chief Executive Officer of MIP Technologies AB, Chairman-Supervisory Board of F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH, Director of BioVeris Corp.
and IGEN International, Inc., Head-Biochemistry at the University of Bath, and Chief Scientific Officer of Biotage AB. He holds a doctorate degree from the University of Oxford.
Postes actifs de Anthony Robert Rees
| Sociétés | Poste | Début |
|---|---|---|
SpinChem AB
SpinChem AB Industrial ConglomeratesProducer Manufacturing Provides tools for chemical processes and reactions | Président | - |
Anciens postes connus de Anthony Robert Rees
| Sociétés | Poste | Fin |
|---|---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Président | 14/05/2012 |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Directeur/Membre du Conseil | 08/04/2011 |
BioVeris Corp.
BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Directeur/Membre du Conseil | 28/06/2007 |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1993 |
| BIOTAGE AB | Directeur Technique/Scientifique/R&D | - |
Formation de Anthony Robert Rees
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
BioVeris Corp.
BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotage AB
Biotage AB Medical SpecialtiesHealth Technology Develops workflow solutions, instruments and consumables used in drug discovery & pharmaceutical development | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Molecular Group Plc
Oxford Molecular Group Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, chemicals,services in informatics and computation. | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Sulis Innovation Ltd. | |
MIP Technologies AB
MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services Develops molecularly imprinted polymers | Commercial Services |
SpinChem AB
SpinChem AB Industrial ConglomeratesProducer Manufacturing Provides tools for chemical processes and reactions | Producer Manufacturing |
















